MAR-COF CG
- Product NDC
- 0682-0475
- 11-digit product format
- 006820475
- Labeler code
- 0682
- Product ID
- 0682-0475_13b802bb-b30a-864a-e063-6394a90a4dfd
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- CODEINE PHOSPHATE and GUAIFENESIN
- Dosage form
- SYRUP
- Route
- ORAL
- Labeler
- Marnel Pharmaceuticals, LLC
- Application
- M012
- Marketing category
- OTC MONOGRAPH DRUG
- Marketing start
- 2008-12-01
- Substance
- CODEINE PHOSPHATE; GUAIFENESIN
- Active strength
- 7.5; 225 mg/5mL; mg/5mL
- Pharmacologic classes
- Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Full Opioid Agonists [MoA], Increased Respiratory Secretions [PE], Opioid Agonist [EPC]
- DEA schedule
- CV
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Observed NDC auxiliary status history#
This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
| Captured / source date | Dataset | Scope | Package NDC | Snapshot | Source SHA-256 |
|---|---|---|---|---|---|
| 2024-03-11 06:39 UTC · source 2024-03-08 | excluded product | product | 1332a3947898… | d4bfe170f9cd… | |
| 2024-03-11 06:39 UTC · source 2024-03-08 | excluded package | package | 0682-0475-16 | 1332a3947898… | d4bfe170f9cd… |
| 2022-08-30 03:57 UTC · source 2022-08-29 | excluded product | product | fb8cb913e6d1… | eb8c232b6be0… | |
| 2022-08-30 03:57 UTC · source 2022-08-29 | excluded package | package | 0682-0475-16 | fb8cb913e6d1… | eb8c232b6be0… |
| 2022-04-09 23:13 UTC · source 2022-04-08 | excluded product | product | 86f5da6cb304… | a595104c45d7… | |
| 2022-04-09 23:13 UTC · source 2022-04-08 | excluded package | package | 0682-0475-16 | 86f5da6cb304… | a595104c45d7… |
| 2022-04-04 05:40 UTC · source 2022-04-01 | excluded product | product | bd6a592717d7… | 303034d00443… | |
| 2022-04-04 05:40 UTC · source 2022-04-01 | excluded package | package | 0682-0475-16 | bd6a592717d7… | 303034d00443… |
| 2021-12-27 23:28 UTC · source 2021-12-27 | excluded product | product | 8dfbde2a14a4… | c9ff85d89658… | |
| 2021-12-27 23:28 UTC · source 2021-12-27 | excluded package | package | 0682-0475-16 | 8dfbde2a14a4… | c9ff85d89658… |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- MAR-COF CG
- Brand name suffix
- Expectorant
- Listing expiration
- 2027-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| CODEINE PHOSPHATE | 7.5 mg/5mL |
| GUAIFENESIN | 225 mg/5mL |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| GSL05Y1MN6 | Internal UNII lookup |
| 495W7451VQ | Internal UNII lookup |
Harmonized RxCUI identifiers#
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| 60a41229-b125-43d8-b2b4-0bf40feed764 | Available on FDA.report |
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
| Effective | Related label |
|---|---|
| 2024-03-15 | MAR-COF ® CG Expectorant |
| 2024-01-30 | MAR-COF ® CG Expectorant |
| 2022-10-17 | MAR-COF ® CG Expectorant |
| 2021-07-23 | MAR-COF ® CG Expectorant |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 0682-0475-16 | MAR-COF CGExpectorant | 473 mL in 1 BOTTLE | SYRUP | 473 | 5 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 0682-0475-16 | ML - Milliliter | 0682-0475 | 96e067ee-d836-4dbd-aa6a-1ca12507d95b | 1 | 2014-02-04 |
DailyMed Socrata Ingredients#
DailyMed Dashboard NDC Coverage#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| daytime cold and flu nighttime cold and flu | ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, PHENYLEPHRINE HYDROCHLORIDE, DOXYLAMINE SUCCINATE | Meijer, Inc. | df31056b-d0eb-4094-98d9-3d444210d50d | 2025-01-16 | Warnings | M012 |
| Childrens Ibuprofen Oral Suspension | IBUPROFEN | Reliable 1 Laboratories LLC | 28dd9baa-43bd-b60a-e063-6394a90a8cf7 | 2025-01-15 | Warnings | M012 |
| Guaifenesin | GUAIFENESIN | Reliable 1 Laboratories LLC | ae469d4f-91c4-cff0-e053-2995a90a0497 | 2025-01-15 | Warnings | M012 |
| Diphenhydramine HCL 25 mg | DIPHENHYDRAMINE HCL | Reliable 1 Laboratories LLC | 32f58cb3-941f-263b-e054-00144ff8d46c | 2025-01-15 | Warnings | M012 |
| Diphenhydramine HCl 25 mg | DIPHENHYDRAMINE HCL | Reliable 1 Laboratories LLC | 32fa40ad-fed5-586f-e054-00144ff88e88 | 2025-01-15 | Warnings | M012 |
| CVS Health Chest Congestion and Cough HBP SOFTGEL | DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN | CVS Pharmacy, Inc | 2741ba44-1cc7-1812-e063-6394a90a8faa | 2025-01-14 | Warnings | M012 |
| DAY COLD AND FLU | ACETAMINOPHEN, DEXTROMETHORPHAN HBR, GUAIFENESIN, PHENYLEPHRINE HCL | TARGET CORPORATION | 2b941963-8a8c-4148-e063-6294a90a1dfb | 2025-01-13 | Warnings | M012 |
| Diphenhydramine HCL | DIPHENHYDRAMINE HCL | SDA Laboratories, Inc. | 437e6a13-a4ff-4f98-8973-042f224ee85e | 2025-01-13 | Warnings | M012 |
| Diphenhydramine HCL | DIPHENHYDRAMINE HCL | SDA Laboratories, Inc. | 6a520986-1004-4ee6-9a47-1dfd90bb1b2c | 2025-01-13 | Warnings | M012 |
| good sense daytime | ACETAMINOPHEN, DEXTROMETHORPHAN HBR, PHENYLEPHRINE HCL | L. Perrigo Company | 5ddf3283-94e4-465d-842a-471ee946c330 | 2025-01-10 | Warnings | M012 |
| Vicks VapoSteam | CAMPHOR (SYNTHETIC) | Kaz USA, Inc | c28da455-07ad-4053-8b9e-fc559f9a3f72 | 2025-01-10 | Warnings | M012 |
| Guaifenesin 200mg | GUAIFENESIN | Aphena Pharma Solutions - Tennessee, LLC | 45ac210a-8c54-4469-8e10-e6fe52b89cb5 | 2025-01-09 | Warnings | M012 |
| Meclizine HCL | MECLIZINE HCL 25MG CHEWABLE TABLETS | Aphena Pharma Solutions - Tennessee, LLC | 02d1af4d-d97d-4019-a5bf-3ec391238676 | 2025-01-09 | Warnings | M012 |
| HISTEX PD Drops New Formulation | TRIPROLIDINE HYDROCHLORIDE | Allegis Pharmaceuticals, LLC | 0c693f15-5d76-3dbf-e063-6294a90af9ac | 2025-01-08 | Warnings | M012 |
| DEXTROMETHORPHAN HBR 15 MG | DEXTROMETHORPHAN HBR 15 MG | AMZ789 LLC | e2175017-6a0d-0155-e053-2995a90a65d6 | 2025-01-08 | Warnings | M012 |
| Nighttime Cold and Flu | ACETAMINOPHEN, DOXYLAMINE SUCCINATE, DEXTROMETHORPHAN HBR | Health Pharma USA LLC | 29bb7822-76c6-e39d-e063-6294a90a64fb | 2025-01-07 | Warnings | M012 |
| Childrens Allergy Relief | CHILDRENS ALLERGY RELIEF | Allegiant Health | cb6df361-b8e5-4e2f-945f-c20159d76c4f | 2025-01-06 | Warnings | M012 |
| Nasal Decongestant PE Maximum Strength | PHENYLEPHRINE HCL | WinCo Foods, LLC | bb7a9fed-dc04-4c31-aa7f-4185d955242c | 2025-01-06 | Warnings | M012 |
| Leader Childrens Cold and Cough | BROMPHENIRAMINE MALEATE, DEXTROMETHORPHAN HYDROBROMIDE | Cardinal Health 110, LLC. dba Leader | 207b2677-aaad-4fe4-a96d-963b7dcfba70 | 2025-01-06 | Warnings | M012 |
| Allergy Relief Caplet | DIPHENHYDRAMINE HYDROCHLORIDE | TOPCO ASSOCIATES LLC | 126c05e7-2cd9-47d3-96c3-82305714e1db | 2025-01-02 | Warnings | M012 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 995441 | codeine phosphate 7.5 MG / guaiFENesin 225 MG in 5 mL Oral Solution | PSN | 60a41229-b125-43d8-b2b4-0bf40feed764 | 5 |
| 995443 | MAR-COF CG 7.5 MG / 225 MG in 5 mL Oral Solution | PSN | 60a41229-b125-43d8-b2b4-0bf40feed764 | 5 |
| 995443 | codeine phosphate 1.5 MG/ML / guaifenesin 45 MG/ML Oral Solution [Mar-cof CG] | SBD | 60a41229-b125-43d8-b2b4-0bf40feed764 | 5 |
| 995441 | codeine phosphate 1.5 MG/ML / guaifenesin 45 MG/ML Oral Solution | SCD | 60a41229-b125-43d8-b2b4-0bf40feed764 | 5 |
| 995441 | codeine phosphate 7.5 MG / guaifenesin 225 MG per 5 ML Oral Solution | SY | 60a41229-b125-43d8-b2b4-0bf40feed764 | 5 |
| 995443 | Mar-cof CG (codeine phosphate 7.5MG / guaifenesin 225 MG) per 5 ML Oral Solution | SY | 60a41229-b125-43d8-b2b4-0bf40feed764 | 5 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 0682-0475-16 | 00682047516 | 473 mL in 1 BOTTLE (0682-0475-16) | 473 ml | 2008-12-01 | 0000-00-00 | No | No | Current |